Vazculep FDA Approval History
Last updated by Judith Stewart, BPharm on March 2, 2021.
FDA Approved: Yes (First approved June 27, 2014)
Brand name: Vazculep
Generic name: phenylephrine hydrochloride
Dosage form: Injection
Company: Flamel Technologies
Treatment for: Hypotension
Vazculep (phenylephrine hydrochloride) injection is an alpha-1 adrenergic receptor agonist indicated for the treatment of hypotension resulting primarily from vasodilation in the setting of anesthesia.
Development timeline for Vazculep
| Date | Article |
|---|---|
| Jun 30, 2014 | Approval Flamel Technologies Announces FDA Approval of Vazculep |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
